Pregled bibliografske jedinice broj: 979759
Socio-demographic risk factors for high HEV seroprevalence among liver transplant recipients in Croatia
Socio-demographic risk factors for high HEV seroprevalence among liver transplant recipients in Croatia // 4th Central and Eastern European Meeting on Viral Hepatitis and HIV: book of abstracts
Prag, Češka Republika: Reviews in Antiviral Therapy & Infectious Diseases, 2018. str. 6-6 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 979759 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Socio-demographic risk factors for high HEV
seroprevalence among liver transplant recipients
in Croatia
Autori
Mrzljak, Anna ; Dinjar Kujundžić, Petra ; Đaković Rode, Oktavija ; Kolarić, Branko ; Vince, Adriana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
4th Central and Eastern European Meeting on Viral Hepatitis and HIV: book of abstracts
/ - : Reviews in Antiviral Therapy & Infectious Diseases, 2018, 6-6
Skup
4th Central and Eastern European Meeting on Viral Hepatitis and HIV
Mjesto i datum
Prag, Češka Republika, 11.10.2018. - 12.10.2018
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
hepatitis E virus ; seroprevalence ; liver transplantation ; risk factors ; socio-demographic risk factors ; Croatia
Sažetak
Background: Hepatitis E virus (HEV) is an emerging disease in Europe, especially important among solidorgan transplant (SOT) recipients who are at greater risk of developing acute and chronic hepatitis with progression to cirrhosis. The foodborne transmission is considered the main route of HEV infection in developed countries. However, risk factors for the HEV acquisition among SOT recipients are still incompletely understood. The aim of this study was to determine the HEV exposure in LT cohort and to identify sociodemographic risk factors related to HEV seropositivity. Methods: 242 Croatian liver transplant (LT) recipients completed a risk factor assessment questionnaire and were screened for anti-HEV IgG during post- transplant outpatient visits. Blood samples were tested for antiHEV IgG using an enzyme immune assay (Mikrogen, Germany), confirmed by Western blot (Mikrogen, Germany). Results: Anti-HEV IgG seroprevalence in LT recipients was 24.38%. The median time after LT was 5 years (range 19 years). The majority of the recipients were male (69.0%) and the major indication for LT was alcoholic liver disease (50.4%). The HEV seroprevalence in our transplant cohort was associated with older age (OR=1.05 ; 95%CI=1.02- 1.09), female gender (OR=2.61 ; 95%CI=1.42-4.81), rural area of residence (AOR=2.17 ; 95%CI=1.10- 4.27), and specific factors within a household, a farm (AOR=2.79 ; 95% CI=1.31-5.92), a water-well (AOR=3.09 ; 95%CI=1.11-8.57) and a sewage system connected to a septic tank (AOR=3.38 ; 95%CI=1.64-6.95). The highest level of education (AOR=0.05 ; 95%CI=0.01- 0.43) and a recent travelling experience (AOR=0.39 ; 95%CI=0.17- 0.88) were linked to a lower HEV seroprevalence. Contrary to initial assumptions, production and/or consummation of cured meat and occupational exposure had no statistically significant strength of association with antiHEV IgG seropositivity. Conclusion: Our results show that anti-HEV IgG seroprevalence is high (24.38%) among LT recipients in South-eastern Europe (Croatia). The identified sociodemographic factors associated with the seropositvity set up a platform for further research directions to evaluate sources/routes of transmission and clinical impact of HEV infection after solid- organ transplantation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Hrvatski zavod za javno zdravstvo,
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Adriana Vince
(autor)
Oktavija Dakovic Rode
(autor)
Branko Kolarić
(autor)
Anna Mrzljak
(autor)